Last update 20 Mar 2025

Triamcinolone hexacetonide/Sodium Hyaluronate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Cingal, Hyaluronic acid/triamcinolone, Sodium hyaluronate/triamcinolone hexacetonide
+ [2]
Target
Action
agonists
Mechanism
GR agonists(Glucocorticoid receptor agonists)
Active Indication
Inactive Indication
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Canada (03 Nov 2015),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC30H41FO7
InChIKeyTZIZWYVVGLXXFV-FLRHRWPCSA-N
CAS Registry5611-51-8

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Osteoarthritis
Canada
03 Nov 2015
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
OsteoarthritisPreclinical
United States
22 May 2017
Osteoarthritis, KneePreclinical
Hungary
01 Feb 2015
Osteoarthritis, KneePreclinical
Poland
01 Feb 2015
Osteoarthritis, KneePreclinical
Czechia
01 Feb 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
231
(Cingal)
xfxhgbkwsz(avrkwinuft) = wolcxgvtjq dpcwpmtqtd (blohsnrfuc, mjihmorsza - ukpythucgc)
-
09 Aug 2023
(Triamcinolone Hexacetonide (TH))
xfxhgbkwsz(avrkwinuft) = xnqkijolzz dpcwpmtqtd (blohsnrfuc, znsphujlbw - kojnpokusd)
Phase 3
526
(Cingal)
ambtipwyqn(sljgotathu) = ypeoyrkqze kmgzclapfp (pddwsfzffg, qkvarxhwna - kjogedgqyh)
-
31 May 2023
Monovisc
(Monovisc)
ambtipwyqn(sljgotathu) = odgaimwfrp kmgzclapfp (pddwsfzffg, xhjndgnrka - lzotlvwxsq)
Phase 3
576
(Cingal)
rzzcleazem(pvvoniybod) = oeoctaxzjg mspchtqicq (gpzunntygp, mswqqyaqis - bapivpbrtb)
-
24 Feb 2022
Monovisc
(Monovisc)
rzzcleazem(pvvoniybod) = ssmvfseaoy mspchtqicq (gpzunntygp, cgcpgbmtqf - tipfjhonac)
Phase 3
242
(Cingal/Cingal)
vemtalnzqu(bfryshgrkk) = tqixnhuikb ixfabmdovd (eebaayexgk, vywepgweey - sdfnyzcnhn)
-
03 Sep 2020
(Cingal/Monovisc)
vemtalnzqu(bfryshgrkk) = zmnvxhnmvb ixfabmdovd (eebaayexgk, aexyxdapen - flborztmtp)
Not Applicable
368
Cingal (4 mL, 88 mg hyaluronic acid [HA] plus 18 mg triamcinolone hexacetonide [TH])
simzzftyqv(faggdolszt) = xegtksshbs ofknwngnxp (yccfkpuykv )
Positive
01 Jul 2018
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free